Kovack Advisors, Inc. Pfizer Inc Call Options Transaction History

Kovack Advisors, Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $131 - $160	-3 Reduced 23.08%	10 $0
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1,555 - $1,927	-34 Reduced 72.34%	13 $0
Q4 2021 Jan 18, 2022	BUY	$41.32 - $61.25 $330 - $490	8 Added 20.51%	47 $30,000
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $1,138 - $1,462	29 Added 290.0%	39 $7,000
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $35 - $40	1 Added 11.11%	10 $1,000

Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $167 - $188	-5 Reduced 35.71%	9 $1,000
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $167 - $212	5 Added 55.56%	14 $2,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $285 - $335	9 New	9 $1,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.